Immunohistochemical localization of metallothionein in endometrial lesions

Journal of Pathology

Volumn 191, Issue 3, 2000, Pages 269-273

  Ioachim, Elli E ^a   Kitsiou, Evangelia ^a   Carassavoglou, Catherin ^a   Stefanaki, Stella ^a   Agnantis, N J ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Bcl 2; Endometrial lesions; ER; Metallothionein; MIB1; P53; PCNA; PgR

Indexed keywords

ESTROGEN RECEPTOR; METALLOTHIONEIN; PROGESTERONE RECEPTOR; PROTEIN BCL 2; PROTEIN P53;

ARTICLE; CELL PROTECTION; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; HEAVY METAL POISONING; HORMONAL REGULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

ADULT; ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; METALLOTHIONEIN; MIDDLE AGED; NEOPLASM PROTEINS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0033946105     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-9896(2000)9999:9999<::AID-PATH616>3.0.CO;2-Q     Document Type: Article

References (30)

1. Kagi JHR. Overview of metallothionein. Methods Enzymol 1991; 205: 613-626.
2. Masters BA, Kelly EJ, Quaife CJ, Brinsler RL, Palmiter RD. Targeted disruption of metallothionein I and II genes increases sensitivity to cadmium. Proc Natl Acad Sci U S A 1994; 91: 584-588.
3. Hamer DH. Metallothionein. Annu Rev Biochem 1986; 55: 913-951.
4. Slater ER, Cato ACB, Karin M, Baxter JD, Beato M. Progesterone induction of metallothionein-IIA gene expression. Mol Endocrinol 1988; 2: 485-491.
5. Vandenood JJ, Deley M. Distribution of metallothionein in normal and pathological human skin. Arch Dermatol Res 1994; 286: 62-68.
6. Jasani B, Elmes ME. Immunohistochemical detection of metallothionein. Methods Enzymol 1991; 205: 95-107.
7. Nartey N, Cherian G, Banerjee D. Immunohistochemical localization of metallothionein in human thyroid tumors. Am J Pathol 1987; 129: 177-182.
8. Riordan JR, Richards V. Human fetal liver contains both zinc and copper-rich forms of metallothionein. J Biol Chem 1980; 255: 5380-5384.
9. Fresno M, Wu W, Rodriguez JM, Nadji M. Localisation of metallothionein in breast carcinomas. An immunohistochemical study. Virchows Arch A 1993; 423: 215-219.
10. Haerslev T, Jackobsen K, Nedergaard L, Zedeler K. Immunohistochemical detection of metallothionein in primary breast carcinomas and their axillary lymph node metastases. Pathol Res Pract 1994; 190: 675-681.
11. Schmid KW, Ellis IO, Gee JMW, et al. Presence and possible significance of immuno ytochemically demonstrable metallothionein over-expression in primary invasive ductal carcinoma of the breast. Virchows Arch A 1993; 422: 153-159.
12. Douglas-Jones AG, Schmid KD, Bier B, et al. Metallothionein expression in duct carcinoma in situ of the breast. Hum Pathol 1995; 26: 217-222.
13. Zeiger B, Hittmair A, Schir M, Ofner C, et al. Immunohistochemically demonstrated metallothionein expression in malignant melanoma. Histopathology 1993; 23: 257-264.
14. Ohshio G, Imamura T, Okada N, et al. Immunohistochemical study of metallothionein in pancreatic carcinomas. J Cancer Res Clin Oncol 1996; 122: 351-355.
15. McCluggage WG, Maxwell P, Hamilton PW, Jasani B. High metallothionein expression is associated with features predictive of aggressive behaviour in endometrial carcinoma. Histopathology 1999; 34: 51-55.
16. Ofner D, Maier H, Riedmann B. et al. Immunohistochemical metallothionein expression in colorectal adenocarcinoma: correlation with tumor stage and patient survival. Virchows Arch 1994; 425: 491-497.
17. Cherian MG, Huang PC, Klaassen CD, Liu Y-P. Longfellow DG, Waalkes MP. National Cancer Institute workshop on the possible roles of metallothionein in carcinogenesis. Cancer Res 1993; 53: 922-925.
18. Hainaut P. Milner J. A structural role for metal ions in the 'wild-type' conformation of the tumour suppressor protein p53. Cancer Res 1993; 53: 1739-1742.
19. Zeng J, Heuchel R, Schaffner W, Kagi JHR. Thionein (apothionein) can modulate DNA binding and transcription activation by zinc linger containing factor SP1. FEBS Lett 1991; 179: 310-312.
20. Abdel-Mageed AB, Agrawal KC. Anti-sense down-regulation of metallothionein induces growth arrest and apoptosis in human breast carcinoma cells. Cancer Gene Ther 1996; 3 (Supp): 93.
21. Silverberg SG, Kurman RJ. Endometrial carcinoma. In Atlas of Tumor Pathology. Tumors of the Uterine Corpus and Gestational Trophoblastic Disease (3rd edn). Armed Forces Institute of Pathology. Springer-Verlag: Washington, DC, 1991; 47-90.
22. Hsu SM, Raine L, Fanger H. Use of avidin biotin peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabelled antibody (PAP) procedures. J Histochem Cytochem 1981; 29: 577-580.
23. Schmid KW, Morgan JM, Ofner D, Hiltmair A, Haywood S, Jasani B. Quantitative immunocytochemical evaluation by image analysis of metallothionein in copper-loaded rat kidney. J Histochem Cytochem 1993; 41: 727-731.
24. Bier B, Douglas-Jones A, Totsch M, et al. Immunohistochemical demonstration of metallothionein in normal human breast tissue and benign and malignant breast lesions. Breast Cancer Res Treat 1994; 30: 213-221.
25. Abeler VM, Kjorstad KE. Endometrial adenocarcinoma with squamous cell differentiation. Cancer 1992; 69: 488-495.
26. Zaino RJ, Kurman RJ, Herbold D, et al. The significance of squamous differentiation in endometrial carcinoma: data from a Gynecologic Oncology Group study. Cancer 1991; 68: 2293-3202.
27. Creasman WT. Prognostic significance of hormone receptors in endometrial cancer. Cancer 1993; 71: 1467-1470.
28. Carcangiu ML, Chambers JT, Voynick IM, Pirro M, Schwartz PE. Immunohistochemical evaluation of estrogen and progesterone receptor content in 183 patients with endometrial carcinoma. Part I: clinical and histologic correlations. Am J Clin Pathol 1990; 94: 247-254.
29. Kleine W, Maier T, Geyer H, Pfleiderer A. Estrogen and progesterone receptors in endometrial cancer and their prognostic relevance. Gynecol Oncol 1990; 38: 59-65.
30. Jasani BH, Campbell F, Navabi H, Schmid K, Williams G. Clonal overexpression of metallothionein is induced by somatic mutation in orphologically normal colonie mucosa. J Pathol 1998; 184: 144-147.